Linked Data API

Show Search Form

Search Results

1020398
star this property registered interest false more like this
star this property date less than 2018-12-05more like thismore than 2018-12-05
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Abortion: Gender Selection more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when his Department next plans to publish an assessment of the extent of sex selective abortion in the UK. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 199399 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-12-12more like thismore than 2018-12-12
star this property answer text <p>The Department publishes annual sex birth ratio analysis, which provides information on whether there is any evidence for sex selective abortions happening at scale within specific communities in Great Britain. The most recent analysis was published in October 2018 and found no evidence of sex selective abortions occurring in Great Britain over the period 2012 to 2016. The report is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2" target="_blank">https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2</a></p><p> </p><p>The UK National Screening Committee has recommended Non-invasive prenatal testing (NIPT) be a contingent test in the NHS Fetal Anomaly Screening Programme only for trisomy 13, 18, 20 and not for any other genetic marker including sex. Plans are currently underway to make the NIPT test available on the National Health Service for Down’s syndrome, Edwards’ and Patau’s syndromes only.</p><p> </p><p>Sex selection is not one of the lawful grounds for termination of pregnancy. It is illegal for a practitioner to carry out an abortion for that reason alone, unless the certifying practitioners consider that an abortion was justified in relation to at least one of the grounds in the Abortion Act 1967 such as a gender-linked inherited medical condition. Anyone with evidence that sex selective abortion is occurring should report it to the police.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN
199400 more like this
199401 more like this
star this property question first answered
less than 2018-12-12T11:39:19.163Zmore like thismore than 2018-12-12T11:39:19.163Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1020399
star this property registered interest false more like this
star this property date less than 2018-12-05more like thismore than 2018-12-05
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Gender Selection more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, if his Department will take steps to ban the use of non-invasive prenatal testing to determine gender. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 199400 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-12-12more like thismore than 2018-12-12
star this property answer text <p>The Department publishes annual sex birth ratio analysis, which provides information on whether there is any evidence for sex selective abortions happening at scale within specific communities in Great Britain. The most recent analysis was published in October 2018 and found no evidence of sex selective abortions occurring in Great Britain over the period 2012 to 2016. The report is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2" target="_blank">https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2</a></p><p> </p><p>The UK National Screening Committee has recommended Non-invasive prenatal testing (NIPT) be a contingent test in the NHS Fetal Anomaly Screening Programme only for trisomy 13, 18, 20 and not for any other genetic marker including sex. Plans are currently underway to make the NIPT test available on the National Health Service for Down’s syndrome, Edwards’ and Patau’s syndromes only.</p><p> </p><p>Sex selection is not one of the lawful grounds for termination of pregnancy. It is illegal for a practitioner to carry out an abortion for that reason alone, unless the certifying practitioners consider that an abortion was justified in relation to at least one of the grounds in the Abortion Act 1967 such as a gender-linked inherited medical condition. Anyone with evidence that sex selective abortion is occurring should report it to the police.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN
199399 more like this
199401 more like this
star this property question first answered
less than 2018-12-12T11:39:19.24Zmore like thismore than 2018-12-12T11:39:19.24Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1020400
star this property registered interest false more like this
star this property date less than 2018-12-05more like thismore than 2018-12-05
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Abortion: Gender Selection more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what structures are in place for healthcare professionals in (a) primary care and (b) other settings to raise concerns on sex selective abortion occurring. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 199401 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-12-12more like thismore than 2018-12-12
star this property answer text <p>The Department publishes annual sex birth ratio analysis, which provides information on whether there is any evidence for sex selective abortions happening at scale within specific communities in Great Britain. The most recent analysis was published in October 2018 and found no evidence of sex selective abortions occurring in Great Britain over the period 2012 to 2016. The report is available at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2" target="_blank">https://www.gov.uk/government/statistics/sex-ratios-at-birth-in-great-britain-2012-to-2016--2</a></p><p> </p><p>The UK National Screening Committee has recommended Non-invasive prenatal testing (NIPT) be a contingent test in the NHS Fetal Anomaly Screening Programme only for trisomy 13, 18, 20 and not for any other genetic marker including sex. Plans are currently underway to make the NIPT test available on the National Health Service for Down’s syndrome, Edwards’ and Patau’s syndromes only.</p><p> </p><p>Sex selection is not one of the lawful grounds for termination of pregnancy. It is illegal for a practitioner to carry out an abortion for that reason alone, unless the certifying practitioners consider that an abortion was justified in relation to at least one of the grounds in the Abortion Act 1967 such as a gender-linked inherited medical condition. Anyone with evidence that sex selective abortion is occurring should report it to the police.</p>
star this property answering member constituency Thurrock more like this
star this property answering member printed Jackie Doyle-Price more like this
star this property grouped question UIN
199399 more like this
199400 more like this
star this property question first answered
less than 2018-12-12T11:39:19.287Zmore like thismore than 2018-12-12T11:39:19.287Z
star this property answering member
4065
star this property label Biography information for Jackie Doyle-Price more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
1060632
star this property registered interest false more like this
star this property date less than 2019-02-13more like thismore than 2019-02-13
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Medical Treatments more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps the Government is taking to ensure patients will be offered more personalised therapeutic options, as set out in the NHS Long Term Plan. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 220901 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-02-22more like thismore than 2019-02-22
star this property answer text <p>Personalised care means people having choice and control over the way their care is planned and delivered, based on their individual needs and what matters most to them.</p><p>The Long Term Plan set out the ambition for patients get more joined up and personalised care when they need it. As set out in the National Health Service vision paper, Universal Personalised Care – Implementing the Comprehensive Model, NHS England intend to rollout a comprehensive model, based on learning and evidence to date which includes mechanisms to support delivery.</p><p>This will provide support such as personalised care and support planning, and include support for people to have personal health budgets. This is an amount of money to support a person’s identified health and wellbeing needs, planned and agreed between them and their local clinical commissioning group.</p><p>In addition to the vision set out in Universal Personalised Care – Implementing the Comprehensive Model, NHS England has committed to offering all children with cancer whole genome sequencing to enable more comprehensive and precise diagnosis, and access to more personalised treatments. This will reduce the use of harmful medications and interventions, support increased access to clinical trials and reduce the number of young patients who experience lifelong health problems caused by high doses of chemotherapy and radiotherapy.</p><p> </p>
star this property answering member constituency Gosport more like this
star this property answering member printed Caroline Dinenage more like this
star this property question first answered
remove maximum value filtermore like thismore than 2019-02-22T07:47:25.85Z
star this property answering member
4008
star this property label Biography information for Caroline Dinenage more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
833868
star this property registered interest false more like this
star this property date less than 2018-01-30more like thismore than 2018-01-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rare Diseases: Medical Treatments more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to develop an additional appraisal process for new rare disease treatments which do not meet the criteria for the NICE Highly Specialised Technology appraisal route. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 125626 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-07more like thismore than 2018-02-07
star this property answer text <p>The Department has no plans to establish a new assessment process for the evaluation of rare disease treatments that do not meet the criteria for the National Institute for Health and Care Excellence (NICE) Highly Specialised Technology appraisal route. NICE develops guidance on most new drugs through its technology appraisal programme, and has been able to recommend a number of drugs for rare diseases for routine use on the National Health Service.</p><p> </p><p>There is an established topic selection process for the technology appraisal and highly specialised technology evaluation programme that includes a public consultation and is designed to ensure that treatments are only referred for assessment by NICE where its guidance will add value.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-07T16:47:50.59Zmore like thismore than 2018-02-07T16:47:50.59Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
833870
star this property registered interest false more like this
star this property date less than 2018-01-30more like thismore than 2018-01-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading NHS: Drugs more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the time taken to issue guidance once a marketing authorisation has been granted. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 125628 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-07more like thismore than 2018-02-07
star this property answer text <p>Departmental officials regularly meet with officials in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including the timescales for the development of guidance through its technology appraisal (TA) and highly specialised technology (HST) programmes.</p><p> </p><p>Wherever possible, NICE aims to publish TA and HST guidance on new drugs and significant licence extensions within a few months of a drug receiving a marketing authorisation.</p><p> </p><p>The new arrangements for the assessment and adoption of cancer drugs introduced in July 2016 mean that the NICE appraisal process now starts much earlier for newly referred drugs, with the aim of publishing draft guidance before drugs receive their licence, and then final guidance to be issued within 90 days of that.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-07T14:03:15.937Zmore like thismore than 2018-02-07T14:03:15.937Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
833871
star this property registered interest false more like this
star this property date less than 2018-01-30more like thismore than 2018-01-30
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Innovative Medicines and Medical Technology Review more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, when he plans to publish the criteria to access the accelerated access pathway. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 125629 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-07more like thismore than 2018-02-07
star this property answer text <p>As set out in the response to the Accelerated Access Response published in November 2017, the pathway will be developed and owned by the newly created Accelerated Access Collaborative (AAC), a partnership between the National Health Service, industry, and clinical and patient representatives. The AAC met for the first time on 31 January and it will be that group’s responsibility to determine the criteria for the pathway. We anticipate that the AAC will publish further details on the process and criteria for the pathway ahead of the pathway opening in April 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-07T14:05:49.767Zmore like thismore than 2018-02-07T14:05:49.767Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
839251
star this property registered interest false more like this
star this property date less than 2018-02-08more like thismore than 2018-02-08
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Fentanyl: Misuse more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent steps the Government has taken to tackle the misuse of Fentanyl. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 127805 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-02-20more like thismore than 2018-02-20
star this property answer text <p>Public Health England supports local areas in responding to the threat from fentanyl, and other drugs. This includes ensuring wider availability of the opioid-overdose antidote naloxone, providing messages to use with people at risk, and issuing public health alerts when there is sufficient evidence of harm from particular drugs like fentanyl.</p><p>Local authorities are responsible for commissioning drug treatment services and interventions to reduce drug-related harm, based on local need.</p><p>My Rt. hon. Friend the Home Secretary has also asked the Advisory Council on the Misuse of Drugs to investigate the risks around fentanyl analogues, so we can maximise the effectiveness of our response.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-02-20T17:15:15.64Zmore like thismore than 2018-02-20T17:15:15.64Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
851701
star this property registered interest false more like this
star this property date less than 2018-02-28more like thismore than 2018-02-28
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Spinal Muscular Atrophy: Medical Treatments more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what the timetable is for the NICE appraisal of Spinraza for the treatment of spinal muscular atrophy. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 130464 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-03-05more like thismore than 2018-03-05
star this property answer text <p>The National Institute for Health and Care Excellence currently expects to issue final guidance on the use of nusinersen for the treatment of spinal muscular atrophy in November 2018, with a first Appraisal Committee meeting to discuss the topic scheduled for 26 June 2018.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-05T15:55:44.413Zmore like thismore than 2018-03-05T15:55:44.413Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this
851702
star this property registered interest false more like this
star this property date less than 2018-02-28more like thismore than 2018-02-28
star this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
unstar this property answering dept sort name Health and Social Care more like this
star this property hansard heading Nusinersen more like this
star this property house id 1 remove filter
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what progress NHS England and Biogenon have made in discussions on a managed access agreement for the use of Spinraza for the treatment of spinal muscular atrophy. more like this
star this property tabling member constituency North Tyneside remove filter
star this property tabling member printed
Mary Glindon more like this
star this property uin 130465 more like this
unstar this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2018-03-05more like thismore than 2018-03-05
star this property answer text <p>NHS England has advised that it is continuing discussions with Biogen and the National Institute for Health and Care Excellence about the use of nusinersen (Spinraza) for the treatment of patients with spinal muscular atrophy.</p> more like this
star this property answering member constituency Winchester more like this
star this property answering member printed Steve Brine more like this
star this property question first answered
less than 2018-03-05T15:54:12.893Zmore like thismore than 2018-03-05T15:54:12.893Z
star this property answering member
4067
star this property label Biography information for Steve Brine more like this
star this property tabling member
4126
unstar this property label Biography information for Mary Glindon more like this